The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of two ...
Baron Funds, an investment management company, released its “Baron Discovery Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund was ...
Hosted on MSN
Inspire Medical Systems (INSP) Shows Improved Sleep Apnea Outcomes with Inspire V System
Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the best medical device stocks to invest in. On October 10, Inspire Medical Systems, Inc. (NYSE:INSP) published clinical data demonstrating the ...
Hosted on MSN
Physicians Surgical Hospitals completes 100th Inspire procedure for obstructive sleep apnea
AMARILLO, Texas (KAMR/KCIT) — Physicians Surgical Hospitals, Quail Creek campuses, has completed its 100th Inspire procedure for obstructive sleep apnea. According to officials, Inspire is an ...
ATLANTA--(BUSINESS WIRE)--Advanced ENT & Allergy is pleased to welcome Elizabeth Walker Wadsworth, MD, MSCR, a highly trained otolaryngologist from Atlanta’s Buckhead community. Dr. Wadsworth provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results